These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

1332 related articles for article (PubMed ID: 26461090)

  • 1. Structural Design of Engineered Costimulation Determines Tumor Rejection Kinetics and Persistence of CAR T Cells.
    Zhao Z; Condomines M; van der Stegen SJC; Perna F; Kloss CC; Gunset G; Plotkin J; Sadelain M
    Cancer Cell; 2015 Oct; 28(4):415-428. PubMed ID: 26461090
    [TBL] [Abstract][Full Text] [Related]  

  • 2. 4-1BB costimulation ameliorates T cell exhaustion induced by tonic signaling of chimeric antigen receptors.
    Long AH; Haso WM; Shern JF; Wanhainen KM; Murgai M; Ingaramo M; Smith JP; Walker AJ; Kohler ME; Venkateshwara VR; Kaplan RN; Patterson GH; Fry TJ; Orentas RJ; Mackall CL
    Nat Med; 2015 Jun; 21(6):581-90. PubMed ID: 25939063
    [TBL] [Abstract][Full Text] [Related]  

  • 3. CD28 costimulation provided through a CD19-specific chimeric antigen receptor enhances in vivo persistence and antitumor efficacy of adoptively transferred T cells.
    Kowolik CM; Topp MS; Gonzalez S; Pfeiffer T; Olivares S; Gonzalez N; Smith DD; Forman SJ; Jensen MC; Cooper LJ
    Cancer Res; 2006 Nov; 66(22):10995-1004. PubMed ID: 17108138
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Human T cells engineered to express a programmed death 1/28 costimulatory retargeting molecule display enhanced antitumor activity.
    Ankri C; Shamalov K; Horovitz-Fried M; Mauer S; Cohen CJ
    J Immunol; 2013 Oct; 191(8):4121-9. PubMed ID: 24026081
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Advanced generation anti-prostate specific membrane antigen designer T cells for prostate cancer immunotherapy.
    Ma Q; Gomes EM; Lo AS; Junghans RP
    Prostate; 2014 Feb; 74(3):286-96. PubMed ID: 24174378
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Evaluation of Intracellular Signaling Downstream Chimeric Antigen Receptors.
    Karlsson H; Svensson E; Gigg C; Jarvius M; Olsson-Strömberg U; Savoldo B; Dotti G; Loskog A
    PLoS One; 2015; 10(12):e0144787. PubMed ID: 26700307
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Tumor-Targeted Human T Cells Expressing CD28-Based Chimeric Antigen Receptors Circumvent CTLA-4 Inhibition.
    Condomines M; Arnason J; Benjamin R; Gunset G; Plotkin J; Sadelain M
    PLoS One; 2015; 10(6):e0130518. PubMed ID: 26110267
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Polarization effects of 4-1BB during CD28 costimulation in generating tumor-reactive T cells for cancer immunotherapy.
    Li Q; Carr A; Ito F; Teitz-Tennenbaum S; Chang AE
    Cancer Res; 2003 May; 63(10):2546-52. PubMed ID: 12750278
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Excessive Costimulation Leads to Dysfunction of Adoptively Transferred T Cells.
    Wijewarnasuriya D; Bebernitz C; Lopez AV; Rafiq S; Brentjens RJ
    Cancer Immunol Res; 2020 Jun; 8(6):732-742. PubMed ID: 32213625
    [TBL] [Abstract][Full Text] [Related]  

  • 10. CD28 cosignalling does not affect the activation threshold in a chimeric antigen receptor-redirected T-cell attack.
    Chmielewski M; Hombach AA; Abken H
    Gene Ther; 2011 Jan; 18(1):62-72. PubMed ID: 20944680
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Construction and preclinical evaluation of an anti-CD19 chimeric antigen receptor.
    Kochenderfer JN; Feldman SA; Zhao Y; Xu H; Black MA; Morgan RA; Wilson WH; Rosenberg SA
    J Immunother; 2009 Sep; 32(7):689-702. PubMed ID: 19561539
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Costimulation by chimeric antigen receptors revisited the T cell antitumor response benefits from combined CD28-OX40 signalling.
    Hombach AA; Abken H
    Int J Cancer; 2011 Dec; 129(12):2935-44. PubMed ID: 22030616
    [TBL] [Abstract][Full Text] [Related]  

  • 13. 4-1BB costimulation of effector T cells for adoptive immunotherapy of cancer: involvement of Bcl gene family members.
    Kroon HM; Li Q; Teitz-Tennenbaum S; Whitfield JR; Noone AM; Chang AE
    J Immunother; 2007; 30(4):406-16. PubMed ID: 17457215
    [TBL] [Abstract][Full Text] [Related]  

  • 14. High levels of costimulatory receptors OX40 and 4-1BB characterize CD4+CD28null T cells in patients with acute coronary syndrome.
    Dumitriu IE; Baruah P; Finlayson CJ; Loftus IM; Antunes RF; Lim P; Bunce N; Kaski JC
    Circ Res; 2012 Mar; 110(6):857-69. PubMed ID: 22282196
    [TBL] [Abstract][Full Text] [Related]  

  • 15. In vitro stimulation and expansion of human tumour-reactive CD8+ cytotoxic T lymphocytes by anti-CD3/CD28/CD137 magnetic beads.
    Teschner D; Wenzel G; Distler E; Schnürer E; Theobald M; Neurauter AA; Schjetne K; Herr W
    Scand J Immunol; 2011 Aug; 74(2):155-64. PubMed ID: 21517928
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Aberrant Lck Signal via CD28 Costimulation Augments Antigen-Specific Functionality and Tumor Control by Redirected T Cells with PD-1 Blockade in Humanized Mice.
    Gulati P; Rühl J; Kannan A; Pircher M; Schuberth P; Nytko KJ; Pruschy M; Sulser S; Haefner M; Jensen S; Soltermann A; Jungraithmayr W; Eisenring M; Winder T; Samaras P; Tabor A; Stenger R; Stupp R; Weder W; Renner C; Münz C; Petrausch U
    Clin Cancer Res; 2018 Aug; 24(16):3981-3993. PubMed ID: 29748183
    [No Abstract]   [Full Text] [Related]  

  • 17. Improved anti-leukemia activities of adoptively transferred T cells expressing bispecific T-cell engager in mice.
    Liu X; Barrett DM; Jiang S; Fang C; Kalos M; Grupp SA; June CH; Zhao Y
    Blood Cancer J; 2016 Jun; 6(6):e430. PubMed ID: 27258611
    [TBL] [Abstract][Full Text] [Related]  

  • 18. 4-1BB chimeric antigen receptors.
    Campana D; Schwarz H; Imai C
    Cancer J; 2014; 20(2):134-40. PubMed ID: 24667959
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Inclusion of an IgG1-Fc spacer abrogates efficacy of CD19 CAR T cells in a xenograft mouse model.
    Almåsbak H; Walseng E; Kristian A; Myhre MR; Suso EM; Munthe LA; Andersen JT; Wang MY; Kvalheim G; Gaudernack G; Kyte JA
    Gene Ther; 2015 May; 22(5):391-403. PubMed ID: 25652098
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Transgene-enforced co-stimulation of CD4+ T cells leads to enhanced and sustained anti-tumor effector functioning.
    Chang L; Chang WC; McNamara G; Aguilar B; Ostberg JR; Jensen MC
    Cytotherapy; 2007; 9(8):771-84. PubMed ID: 17917884
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 67.